GlassScriptPhysician profile
Lena Phu
NPI 1518690072
$1,751.37
in general payments reported to CMS, 2019-2025
10 companies · $237 in 2025
The $237 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $618 · 2023: $157 · 2024: $739 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $884 · Travel and Lodging: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $884.32 |
| Travel and Lodging | $249.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $636.47 | 2022-2024 | Misight Contact Lens |
| Alcon Vision LLC | $280.93 | 2022-2024 | Dailies Total1, Total30 |
| Johnson & Johnson Vision Care, INC. | $149.41 | 2022 | |
| Bausch & Lomb Americas INC. | $137.17 | 2022-2024 | Infuse, Miebo |
| Horizon Therapeutics Plc | $124.99 | 2022 | |
| Harrow Eye, LLC | $121.84 | 2025 | Vevye |
| Amgen INC. | $114.82 | 2025 | Tepezza |
| Optos, INC. | $87.41 | 2022 | |
| Oyster Point Pharma, INC. | $84.03 | 2023 | Tyrvaya |
| Abbvie INC. | $14.30 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lena Phu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.